Progestin regulation of insulin and insulin-like growth factor I receptors in cultured human breast cancer cells
- 33 Downloads
Recent studies indicate that the insulin receptor (IR) content is higher in breast cancer cells than in normal mammary epithelial cells. This observation has been made both in tissue specimens from patients with breast cancer, and in various human cultured breast cancer cell lines. Investigations have now been undertaken to understand the role of progestins in the regulation of the IR and the closely related insulin like growth factors-I receptor (IGF-I-R). Pretreatment of T-47D cultured human breast cancer cell lines with progestins induced a time and dose dependent increase in IR content. This increase was due primarily to an effect of progestins to increase IR mRNA levels. Other steroid hormones including glucocortocoids, estrogen, and testosterone were without effect. In contrast to their up-regulation of the IR, progestins down-regulated the IGF-I-R at the level of mRNA. An analysis of the processes involved revealed that progestins increased the biosynthesis of a ligand for IGF-I receptor, IGF-II. IGF-II in turn down-regulated the IGF-I-R. Thus these studies indicate that progestins have important effects on both the IR and the IGF-I-R. The effects of progestins on these and other growth factor receptors, therefore, may have an important role in the biology of breast cancers.
Key wordsbreast cancer cells IGF-I receptor IGF-II regulation insulin receptor progestins
Unable to display preview. Download preview PDF.
- 3.Henderson IC, Harris JR, Kinne DW, Hellman S: Cancer of the breast.In DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer, Principles and Practice of Oncology (3d edition). JB Lippincott Company, Philadelphia, 1989.Google Scholar
- 8.Roberts CT Jr, LeRoith D: Molecular aspects of insulin-like growth factors, their binding proteins, and receptors. Baillier's Clin Endocrinol Metab 2:1069–1085, 1988.Google Scholar
- 10.Goldfine ID: The insulin receptor: molecular biology and transmembrane signaling. Endocrinol Rev 8:235–255, 1987.Google Scholar
- 11.Lane G, Siddle NC, Ryder TA, Pryse-Davies J, King RJB, Whitehead MI: Effects of dydrogesteron on the oestrogenized postmenopausal endometrium. Br J Obstet Gynaecol 93:52–62, 1986.Google Scholar
- 12.Norquist SJ: The synthesis of DNA and RNA in human carcinomatous endometrium in short-term incubation in vitro and its response to oestradiol and progesterone. J Endocrinol 48:29–38, 1979.Google Scholar
- 15.Horwitz KB, Freidenberg GR: Growth inhibition and increase of insulin receptors in antiestrogen resistant T47D human breast cancer cells by progestins: implications for the endocrine therapies. Cancer Res 45:167–173, 1987.Google Scholar
- 16.Hissom JR, Bowden RT, Moore MR: Effects of progestins, estrogens and antihormones on growth and lactate dehydrogenases in the human breast cancer cell line T47D. Endocrinol 125:418–423, 1989.Google Scholar
- 34.Pezzino V, Costantino A, Frittitta L, Pappa A, Russo P, Goldfine ID, Vigneri R: Identification and initial characterization of insulin receptor-like immuno-reactivity in human plasma. J Clin Endo Metab (in press), 1992.Google Scholar
- 40.Joyeax C, Rochefort H, Chalbos D: Progestin increases gene transcription and messenger ribonucleic acid stability of fatty acid synthetase in breast cancer cells. Mol Endocrinol 4:681–686, 1989.Google Scholar
- 47.Okabayashi Y, Maddux BA, McDonald AR, Logsdon CD, Williams JA, Goldfine ID: Mechanisms of insulin induced insulin-receptor downregulation: decrease of receptor biosynthesis and mRNA levels. Diabetes 38: 182–187, 1989.Google Scholar